The University of Illinois Cancer Center would like to make you aware of this funding opportunity from the Leukemia & Lymphoma Society. Details below.

Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups

Funder: Leukemia & Lymphoma Society (LLS)

Amount: $2.5 million (The total amount, including both direct and indirect costs, may not exceed $500,000 annually and $2.5 million for a five-year project period.)

Letter of Intent Due: 09/12/2024

Application Due: 01/30/2025

Click to link to Pivot-RP

Abstract: The purpose of this Request for Proposals (RFP) is to fund research studies that will increase our understanding of effective interventions for increasing accrual to therapeutic cancer clinical trials, particularly among underrepresented populations. Specifically, we seek proposals that will implement and evaluate interventions designed to mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups and quantitatively measure the impact of these interventions on patient accrual. We are particularly interested in proposals that address systemic, institutional and clinician-related barriers that impede clinical trial participation.

Click to visit the LLS website for more information.

Translate »